4. Ottery F.Supportive nutritional management of the patient with pancreatic cancer . Oncology.1996;10(9 suppl): 26-32 .
5.
5. Ottery FD.Definition of standardized nutritional assessment and interventional pathways in oncology . Nutrition.1996;12(1 suppl): S15-S19 .
6.
6. Ottery FD.Supportive nutrition to prevent cachexia and improve quality of life . Semin Oncol.1995;22(2 suppl 3): 98-111 .
7.
7. Ottery FD.Rethinking nutritional support of the cancer patient: the new field of nutritional oncology . Semin Oncol.1994;21(6): 770-778 .
8.
8. Ottery FD.Cancer cachexia: prevention, early diagnosis, and management . Cancer Pract.1994;2(2): 123-131 .
9.
9. Grosvenor M , Bulcavage L , Chlebowski RT.Symptoms potentially influencing weight loss in a cancer population. Correlations with primary site, nutritional status, and chemotherapy administration . Cancer.1989;63(2): 330-334 .
11. Delpre G , Stark P , Niv Y.Sublingual therapy for cobalamin deficiency as an alternative to oral and parenteral cobalamin supplementation . Lancet.1999;354(9180): 740-741 .
12.
12. Conly JM , Stein K.Quantitative and qualitative measurements of K vitamins in human intestinal contents . Am J Gastroenterol.1992;87(3): 311-316 .
13.
13. Ottery FD.Bidirectional interplay of nutrition and chemotherapy . Nestle Nutr Workshop Ser Clin Perform Programme.2000;4: 183-202 ; discussion 203-206.
14.
14. McMahon K , Decker G , Ottery FD.Integrating proactive nutritional assessment in clinical practices to prevent complications and cost . Semin Oncol.1998;25(2 Suppl 6): 20-27 .
15.
15. Cox A , McCallum PD.Medical nutrition therapy in palliative care. In: McCallum PD , Polisena CG , eds. The Clinical Guide to Oncology Nutrition. Chicago, Ill: The American Dietetic Association ; 2000:143-149.
16.
16. Homann HH , Kemen M , Fuessenich C , Senkal M , Zumtobel V.Reduction in diarrhea incidence by soluble fiber in patients receiving total or supplemental enteral nutrition . JPEN.1994;18(6): 486-490 .
17.
17. Bass DJ , Forman LP , Abrams SE , Hsueh AM.The effect of dietary fiber in tube-fed elderly patients . J Gerontol Nurs.1996;22(10): 37-44 .
18.
18. Brown KH , Perez F , Peerson JM , et al.Effect of dietary fiber (soy polysaccharide) on severity, duration, and nutritional out-come of acute, watery diarrhea in children . Pediatrics.1993;92(2): 241-247 .
19.
19. Evans MA , Shronts EP.Intestinal fuels: glutamine, short-chain fatty, and dietary fiber . J Am Dietetic Assn.1992;92(10): 1239-1246, 1249 .
20.
20. Savarese D , Al-Zoubi A , Boucher J.Glutamine for irinotecan diarrhea . J Clin Oncol.2000;18(2): 450-451 .
21.
21. Klimberg M.The Clauce H. Organ, Jr. Honorary Lectureship: Glutamine, cancer, and its therapy . Am J Surg.1996;172: 418-424 .
22.
22. Fox AD , Kripke SA , De Paula J , Berman JM , Settle RG , Rombeau JL.Effect of glutamine supplemented enteral diet on methotrexate induced enterocolitis . JPEN.1988;12: 325-331 .
23.
23. Muscaritoli M , Micozzi A , Conversano L , et al.Oral glutamine in the prevention of chemotherapy induced gastrointestinal toxicity . Eur J Cancer.1997;33: 319-320 .
24.
24. Daniele B , Perrone F , Gallo C , et al.Oral glutamine in the prevention of fluorouracil induced intestinal toxicity: a double blind, placebo controlled, randomised trial . Gut.2001;48(1): 28-33 .
25.
25. Skubitz K , Anderson P.Oral glutamine to prevent chemotherapy induced stomatitis: a pilot study . J Lab Clin Med.1996;127: 223-228 .
26.
26. Anderson PM , Schroeder G , Skubitz KM.Oral glutamine reduces the duration and severity of stomatitis after cytotoxic cancer chemotherapy . Cancer.1998;83: 1433-1439 .
27.
27. Berger A , Henderson M , Nadoolman W , et al.Oral capsaicin provides temporary relief for oral mucositis pain secondary to chemotherapy/radiation therapy . J Pain Symp Manage.1995;10(3): 243-248 .
28.
28. Ernst E , Pittler MH.Efficacy of ginger for nausea and vomiting: a systematic review of randomized clinical trials . Br J Anaesth.2000;84(3): 367-371 .
29.
29. Decker-Baumann C , Buhl K , Frohmuller S , von Herbay A , Dueck M , Schlag PM.Reduction of chemotherapy-induced side-effects by parenteral glutamine supplementation in patients with metastatic colorectal cancer . Eur J Cancer.1999;35(2): 202-207 .
30.
30. Oral Glutamine Supplementation for Prevention of Irinotecan Associated Late Diarrhea. Worchester, Mass: UMASS Medical Center .
31.
31. A phase II study of Irinotecan, 5 FU, Leucovorin, and Sulindac and oral glutamine with antioxidants as first line therapy for metastatic colorectal cancer at Hoosier Oncology Group, Indianapolis, Ind.
32.
32. Weidner MS , Sigwart K.The safety of a ginger extract in the rat . J Ethnopharmacol.2000;73(3): 513-520 .
33.
33. Lumb AB.Effect of dried ginger on human platelet function . Thromb Haemost.1994;71(1): 110-111 .
34.
34. Jho D , Babcock TA , Helton WS , Espat NJ.Omega-3 fatty acids: implications for the treatment of tumor-associated inflammation . Am Surg.2003;69(1): 32-36 .
35.
35. Bruera E , Strasser F , Palmer JL , et al.Effect of fish oil on appetite and other symptoms in patients with advanced cancer and anorexia/cachexia: a double-blind, placebo-controlled study . J Clin Oncol.2003;21(1): 129-134 .
36.
36. Harman WE.Omega-3 fatty acids to augment cancer therapy . J Nutr.2002;132(11 Suppl): 3508S-3512S .
37.
37. Barber MD , Fearon KC , Tisdale MJ , McMillan DC , Ross JA.Effect of a fish oil-enriched nutritional supplement on metabolic mediators in patients with pancreatic cancer cachexia . Nutr Cancer.2001;40(2): 118-124 .
38.
38. Barber MD.Cancer cachexia and its treatment with fish-oil-enriched nutritional supplementation . Nutrition.2001;17(9): 751-755 .
39.
39. Wigmore SJ , Barber MD , Ross JA , Tisdale MJ , Fearon KC.Effect of oral eicosapentaenoic acid on weight loss in patients with pancreatic cancer . Nutr Cancer.2000;36(2): 177-184 .
40.
40. Barber MD , McMillan DC , Preston T , Ross JA , Fearon KC.Metabolic response to feeding in weight-losing pancreatic cancer patients and its modulation by a fish-oil-enriched nutritional supplement . Clin Sci.2000;98(4): 389-399 .
41.
41. Barber MD , Ross JA , Voss AC , Tisdale MJ , Fearon KC.The effect of an oral nutritional supplement enriched with fish oil on weight-loss in patients with pancreatic cancer . Br J Cancer.1999;81(1): 80-86 .
42.
42. Barber MD , Fearon KC.Tolerance and incorporation of a high-dose eicosapentaenoic acid diester emulsion by patients with pancreatic cancer cachexia . Lipids.2001;36(4): 347-351 .
43.
43. Burns CP , Halabi S , Claman GH , et al.Phase I clinical study of fish oil fatty acid capsules for patients with cancer cachexia: cancer and leukemia group B study 9473 . Clin Cancer Res.1999;5(12): 3942-3947 .
44.
44. Flora K , Hahn M , Rosen H , Benner K.Milk thistle (Silybum marianum) for the therapy of liver disease . Am J Gastroenterol.1998;93(2): 139-143 .
45.
45. Albrecht M.Therapy of toxic liver pathologies with Legalon . Z Klin Med.1992;47: 87-92 .
46.
46. Palasciano G , Portincasa P , Palmieri V , Ciani D , Vendemiale G , Altomare E.The effect of silymarin on plasma levels of malondialdehyde in patients receiving long-term treatment with psychotropic drugs . Curr Ther Res.1994;55: 537-545 .
47.
47. Zima T , Kamenikova L , Janebova M , Buchar E , Crkovska T , Tesar V.The effect of silibinin on experimental cyclosporine nephrotoxicity . Ren Fail.1998;20: 471-479 .
48.
48. Tyler VE.The Honest Herbal: A Sensible Guide to the Use of Herbs and Related Remedies. 3rd ed.Binghamton, NY:Haworth ; 1993.
49.
49. Robbers JE , Tyler VE.Tyler's Herbs of Choice: The Therapeutic Use of Phytomedicinals. 2nd ed.New York: Haworth ; 1999.
50.
50. Scambia G , De Vincenzo R , Ranelletti FO , et al.Antiproliferative effect of silybin on gynaecological malignancies: synergism with cisplatin and doxorubicin . Eur J Cancer.1996;32A(5): 877-882 .
51.
51. Eaton S , Skinner R , Hale JP , et al. (2000). Plasma coenzyme Q(10) in children and adolescents undergoing doxorubicin therapy . Clin Chim Acta. 2000;302(1-2): 1-9 .
52.
52. Cortes EP , Gupta M , Chou C , Amin VC , Folkers K.Adriamycin cardiotoxicity: early detection by systolic time interval and possible prevention by coenzyme Q10 . Cancer Treat Rep.1978;62(6): 887-889 .
53.
53. Folkers K , Liu M , Watanabe T , Porter TH.Inhibition by adriamycin of the mitochondrial biosynthesis of coenzyme Q10 and implication for the cardiotoxicity of adriamycin in cancer patients . Biochem Biophys Res Commun.1977;77(4): 1536-1542 .
54.
54. Labriola D , Livingston R.Possible interactions between dietary antioxidants and chemotherapy . Oncology (Huntingt).1999;13(7): 1003-1008 ; discussion 1008, 1011-1012.
55.
55. Eckert K , Grabowska E , Stange R , Schneider U , Eschmann K , Maurer HR.Effects of oral bromelain administration on the impaired immunocytotoxicity of mononuclear cells from mammary tumor patients . Oncol Rep.1999;6(6): 1191-1199 .
56.
56. Miller JM , Ginsberg M , McElfatrick GC , Zoll DR.The administration of bromelain orally in the treatment of inflammation and edema . Exp Med Surg.1964;22: 293-399 .
57.
57. Schedler M , Lind A , Schatzle W , Stauder G.Adjuvant therapy with hydrolytic enzymes in oncology—a hopeful effort to avoid bleomycinum induced pneumotoxicity?J Cancer Res Clin Oncol.1990;116(Suppl I): 697 .
58.
58. Gonzalez NJ , Isaacs LL.Evaluation of pancreatic proteolytic enzyme treatment of adenocarcinoma of the pancreas, with nutrition and detoxification support . Nutr Cancer.1999;33(2): 117-124 .
59.
59. Boik J.Natural Compounds in Cancer Therapy. Princeton, Minn: Oregon Medical Press, LLC ; 2001.
60.
60. World Cancer Research Fund/American Institute for Cancer Research . Food, Nutrition, and the Prevention of Cancer: A Global Perspective. Menasha, Wis: BANTA Book Group ; 1997.
